Compound class:
Synthetic organic
Comment: Uracil 20 is a small molecule caspase-1 inhibitor that was developed as a topically active anti-inflammatory agent for the treatment of inflammatory acne [1]. This compound contrasts with the caspase -1 inhibitors belnacasan and pralnacasan which were designed for systemic exposure.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Uracil 20 is >1000 fold selective for caspase-1 compared to the apoptotic caspases 3, 6, 7 and 8, and >300 fold selective for caspase-1 compared to caspase-5 which is also an inflammatory caspase [1]. Uracil 20 inhibits IL-1β production in macrophages (IC50 160 nM) and THP1 human monocytic cells (IC50 38 nM). |
Selectivity at enzymes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|